ANZPID

⚠️ There’s still time to register for tomorrow's insightful discussion with experts on #PneumococcalVaccination and its impact on #SerotypePrevalence. 📅 Date: 18 February 2025 ⏰ Time: 10:00 CET 👉 REGISTER NOW: bit.ly/4aVFgT1 #WSPID #Vaccines #InfectiousDiseases

#JournalClub by Dr Rumeysa Yalcinkaya, Ankara Etlik City Hospital, Türkiye. Study finds no long-term benefit of extended (13–14 day) vs. standard (5–6 day) antibiotics for hospitalised children with CAP. Short course remains effective.🔗 Read more: shorturl.at/sxJ4H

#JournalClub by Drs Krist Ewe, Alayne Bennett, @sambrophyw & @Anita_JCampbell from @PerthChildrens! Global review shows Gram-negative bacteria now dominate neonatal sepsis, challenging outdated classifications & empirical Rx. New approaches needed.🔗 Read shorturl.at/PNRcG

#JournalClub submission by @rcduguid, @thefrancis6, Dr Jen Yan & Dr Te-Yu Hung! Phase 3 trial of #Ziresovir in infants with RSV showed reduced bronchiolitis scores & viral load, but clinical impact is unclear. More studies needed.🔗Read more: shorturl.at/PcdbX

@rcduguid @thefrancis6 @ASIDANZ @afspid @ESPIDsociety @PIDSociety @SLIPEsociedad

Pregnant women can now get a free RSV shot. What other vaccines do you need when you’re expecting? Learn more: ncirs.org.au/pregnant-women… @BiancaMiddlet15 @rns75_doyle @drarchanakoira1 @DanchinMargie @peter_2611 @healthgovau #VaccinesWork #Immunisation #Vaccines

@ASIDANZ @PIDSociety @ESPIDsociety @afspid @SLIPEsociedad @WSPID

Great #JournalClub submission by Drs @nanushka99 & @SamiBannister! Universal #Nirsevimab prophylaxis in infants reduced RSV hospitalisations by 82% & need for O₂ by 86.9% in Spain 🇪🇸. High uptake = rapid, effective immunisation campaign. 🔗Read more: shorturl.at/lVQ6p #RSV

We love these words from @GottliebTom - your @ASIDANZ friends and colleagues are bursting with pride!

Important message from @ASIDANZ

Support our international colleagues as they present the next live @WSPID #journalclub in two weeks on 18/12 at 1am AEST. Aussie colleagues, although not ideal for a live attendance, if you register, you'll be sent the recording after the event. :)

@ASIDANZ and @anzpid response to the Aust Govt #COVID-19 Response Inquiry Report. Pleased to see the emphasis on the importance of an #AustralianCDC. See asid.net.au/news/asid-anzp…

📣 LAST CALL to join us for the October edition of #WSPIDJournalClub! 📅 Date: 31 October 2024 ⏰ Time: 12:00 CEST 👉 REGISTER NOW: bit.ly/3YfIyMd Learn More: bit.ly/3A3aR7j We look forward to seeing you at the session! #WSPID #OnlineEducation #PID

We are thrilled to announce that our president, @AshaBowen, has been recognized as a national leader in #PedsID #research by being elected as a Fellow of the prestigious @AAHMS_health. ➡️Learn more about the impactful #research she was honored for 👉tinyurl.com/yha89p4r

It’s a wrap! What a great ANZPID Clinical meeting. Inspiring sessions and wonderful catch ups with old and new friends. Thank you Dr Angela Berkhout and Dr Sophie Wen for the amazing program. Looking forward to Sydney in 2025! @angieberkhout @DrSophCHWen @ASIDANZ

Dr Ushma Wada (WA), Ms Sarah Risdale (QLD) and Dr Emma Goeman (NSW) sharing the programmatic role out and impact of Nirservimab in their respective states. 85% efficacy in preventing RSV hospitalisations in WA is cause for celebration @ASIDANZ #IDTwitter #medtwitter

The experts are here! Insightful approaches to tricky congenital CMV cases from the perspectives of Dr Renuka Sekar (maternal foetal medicine), Dr Matthew Lynch (paediatric neurology) and A/Prof Julia Clark (paediatric ID) @ASIDANZ #IDTwitter #medtwitter

Let’s get down to business! Great updates and robust discussions presented at the ANZPID business meeting led by our Chair Dr Brendan McMullan, including a plug for the new edition of the Blue Book presented by A/Prof Penelope Bryant @ASIDANZ #IDTwitter #medtwitter

Dr Brendan McMullan delving into the benefits of short course early IV-oral antibiotic switch with the Homefree study @ASIDANZ @brendanmcID #IDTwitter #medtwitter